Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mayekar

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Neuro-Oncology|November 4, 2019
Betacellulin drives therapy resistance in glioblastomaQiwen Fan, Zhenyi An, Robyn A Wong, et al.
Cancer Research|December 13, 2018
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion ProteinsDana S Neel, David V Allegakoen, Victor Olivas, et al.
Cell Reports|August 29, 2019
Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and CancersNilanjana Chatterjee, Evangelos Pazarentzos, Manasi K Mayekar, et al.
The Journal of Clinical Investigation|May 17, 2022
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancerShigeki Nanjo, Wei Wu, Niki Karachaliou, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Neuro-Oncology|November 4, 2019
Betacellulin drives therapy resistance in glioblastomaQiwen Fan, Zhenyi An, Robyn A Wong, et al.
Cancer Research|December 13, 2018
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion ProteinsDana S Neel, David V Allegakoen, Victor Olivas, et al.
Cell Reports|August 29, 2019
Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and CancersNilanjana Chatterjee, Evangelos Pazarentzos, Manasi K Mayekar, et al.
The Journal of Clinical Investigation|May 17, 2022
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancerShigeki Nanjo, Wei Wu, Niki Karachaliou, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 2